177 related articles for article (PubMed ID: 16081118)
1. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species.
Wells PG; Bhuller Y; Chen CS; Jeng W; Kasapinovic S; Kennedy JC; Kim PM; Laposa RR; McCallum GP; Nicol CJ; Parman T; Wiley MJ; Wong AW
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):354-66. PubMed ID: 16081118
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer.
Wells PG; McCallum GP; Chen CS; Henderson JT; Lee CJ; Perstin J; Preston TJ; Wiley MJ; Wong AW
Toxicol Sci; 2009 Mar; 108(1):4-18. PubMed ID: 19126598
[TBL] [Abstract][Full Text] [Related]
3. Oxidative damage in chemical teratogenesis.
Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
[TBL] [Abstract][Full Text] [Related]
4. Receptor- and reactive intermediate-mediated mechanisms of teratogenesis.
Wells PG; Lee CJ; McCallum GP; Perstin J; Harper PA
Handb Exp Pharmacol; 2010; (196):131-62. PubMed ID: 20020262
[TBL] [Abstract][Full Text] [Related]
5. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice.
Kasapinovic S; McCallum GP; Wiley MJ; Wells PG
Free Radic Biol Med; 2004 Dec; 37(11):1703-11. PubMed ID: 15528029
[TBL] [Abstract][Full Text] [Related]
6. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
Parman T; Wiley MJ; Wells PG
Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
[TBL] [Abstract][Full Text] [Related]
7. Biochemical toxicology of chemical teratogenesis.
Wells PG; Winn LM
Crit Rev Biochem Mol Biol; 1996 Feb; 31(1):1-40. PubMed ID: 8744954
[TBL] [Abstract][Full Text] [Related]
8. Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits.
Wells PG; McCallum GP; Lam KC; Henderson JT; Ondovcik SL
Birth Defects Res C Embryo Today; 2010 Jun; 90(2):103-9. PubMed ID: 20544694
[TBL] [Abstract][Full Text] [Related]
9. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
[TBL] [Abstract][Full Text] [Related]
10. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
[TBL] [Abstract][Full Text] [Related]
11. A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture.
Bhuller Y; Wells PG
Toxicol Sci; 2006 Sep; 93(1):156-63. PubMed ID: 16790486
[TBL] [Abstract][Full Text] [Related]
12. Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.
Lee CJ; Gonçalves LL; Wells PG
Toxicol Sci; 2011 Jul; 122(1):146-56. PubMed ID: 21505090
[TBL] [Abstract][Full Text] [Related]
13. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
Bhuller Y; Jeng W; Wells PG
Toxicol Sci; 2006 Sep; 93(1):146-55. PubMed ID: 16714389
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E.
Chen CS; Wells PG
Carcinogenesis; 2006 Jul; 27(7):1358-68. PubMed ID: 16401638
[TBL] [Abstract][Full Text] [Related]
15. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis.
Winn LM; Wells PG
Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124
[TBL] [Abstract][Full Text] [Related]
16. Antisense evidence for nuclear factor-kappaB-dependent embryopathies initiated by phenytoin-enhanced oxidative stress.
Kennedy JC; Memet S; Wells PG
Mol Pharmacol; 2004 Sep; 66(3):404-12. PubMed ID: 15322231
[TBL] [Abstract][Full Text] [Related]
17. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
Lee CJ; Gonçalves LL; Wells PG
FASEB J; 2011 Jul; 25(7):2468-83. PubMed ID: 21502285
[TBL] [Abstract][Full Text] [Related]
18. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
19. Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoin-enhanced oxidative stress.
Abramov JP; Wells PG
Toxicol Sci; 2011 Apr; 120(2):428-38. PubMed ID: 21252394
[TBL] [Abstract][Full Text] [Related]
20. Role of endogenous oxidative DNA damage in carcinogenesis: what can we learn from repair-deficient mice?
Epe B
Biol Chem; 2002; 383(3-4):467-75. PubMed ID: 12033436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]